Tuesday, November 5, 2024
HomeTagsONCOPREX

ONCOPREX

Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics